APA (7th ed.) Citation

CH, W., WC, C., HY, C., PH, C., MH, L., & CH, L. (2026). Association of dual SGLT-2 inhibitor and GLP-1 receptor agonist therapy with colon cancer risk in post-polypectomy patients with diabetes: A target trial emulation. Diabetology & metabolic syndrome, 18(1), . https://doi.org/10.1186/s13098-026-02151-x

Chicago Style (17th ed.) Citation

CH, Wang, Chang WC, Chen HY, Chen PH, Lin MH, and Lee CH. "Association of Dual SGLT-2 Inhibitor and GLP-1 Receptor Agonist Therapy with Colon Cancer Risk in Post-polypectomy Patients with Diabetes: A Target Trial Emulation." Diabetology & Metabolic Syndrome 18, no. 1 (2026). https://doi.org/10.1186/s13098-026-02151-x.

MLA (9th ed.) Citation

CH, Wang, et al. "Association of Dual SGLT-2 Inhibitor and GLP-1 Receptor Agonist Therapy with Colon Cancer Risk in Post-polypectomy Patients with Diabetes: A Target Trial Emulation." Diabetology & Metabolic Syndrome, vol. 18, no. 1, 2026, https://doi.org/10.1186/s13098-026-02151-x.